CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 50 enrolled
Drug / intervention
FPH Pilairo Q CPAP mask +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02121912
NCT02121912N/ACompleted
CompareCT.gov

Pilairo Q In-lab Market Research - Europe

Fisher and Paykel Healthcare·interventional·Posted Apr 24, 2014·Updated Jun 24, 2019

In Brief

A clinical study evaluating FPH Pilairo Q CPAP mask and Any other market released nasal or nasal-pillow CPAP mask for Obstructive Sleep Apnea. Completed, enrolled 50 participants across 1 site.

Detailed Summary

Participants will undergo a normal sleep study. They will be randomised to use either a FPH Pilairo Q nasal pillow CPAP mask, or another mask. The sleep technician will record leak and pressure data, and complete questionnaires regarding satisfaction and ease of use at the end of the night. It is hypothesised that the Pilairo Q mask will be superior to other standard masks for CPAP therapy in terms of ease of use, satisfaction and overall titration experience.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsObstructive Sleep Apnea
CountriesGermany
Collaborators--

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedApr 24, 2014
Enrollment StartJun 1, 2014
Primary CompletionNov 1, 2014
Study CompletionApr 1, 2016
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 12.2 years ago

Interventions

FPH Pilairo Q CPAP maskdevice

CPAP nasal-pillow mask

Any other market released nasal or nasal-pillow CPAP maskdevice

Any other market released nasal or nasal-pillow CPAP mask